| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 05/06/2005 | CA2543606A1 Resolution of 3-amino alkylnitriles |
| 05/06/2005 | CA2543570A1 Acylurea connected and sulfonylurea connected hydroxamates |
| 05/06/2005 | CA2543419A1 Ccr3 receptor antagonists |
| 05/06/2005 | CA2542695A1 Substituted benzylaminoalkylene heterocycles |
| 05/06/2005 | CA2542064A1 Tao kinase modulators and methods of use |
| 05/06/2005 | CA2539967A1 Amides that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 05/06/2005 | CA2539726A1 4-azole substituted imidazole compositions useful as inhibitors or c-met receptor tyrosine kinase |
| 05/06/2005 | CA2538630A1 Novel compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
| 05/06/2005 | CA2538134A1 Novel imidazole derivatives and their use as pharmaceutical agents |
| 05/06/2005 | CA2538131A1 Novel triarylimidazoles |
| 05/05/2005 | US20050096473 Reacting 1,1'-thiocarbonyldiimidazole with an aryl amine, e.g., benzylamine, to form 1830 thiourea (or urea)prodoucts; high speed, automatic process; anticarcinogenic agents, leukemia; enzyme inhibitors for HIV reverse transcriptase (polymerase) |
| 05/05/2005 | US20050096368 Heterocyclo-substituted imidazoles for the treatment of inflammation |
| 05/05/2005 | US20050096358 Treating rheumatoid arthritis, psoriasis, reperfusion injury, cardiovascular , autoimmune, inflammatory disorders and bronchial asthma |
| 05/05/2005 | US20050091764 Coloring keratin fibers, hair |
| 05/04/2005 | EP1528058A1 Polymorphic crystalline forms of celecoxib |
| 05/04/2005 | EP1527343A2 Organic compounds |
| 05/04/2005 | EP1527068A2 Novel arylimidazole derivatives, preparation and therapeutic uses thereof |
| 05/04/2005 | EP1526917A2 Novel nickel-carbene, palladium-carbene and platinum-carbene complexes, their production and use in catalytic reactions |
| 05/04/2005 | CN1200000C Cyclie somatostatin analogs |
| 05/04/2005 | CN1199971C Quaternary ammonium compounds as tachykinin antagonists |
| 05/04/2005 | CN1199953C Preparation method of tinidazole |
| 05/04/2005 | CN1199952C Chemosynthesis method of 1-choroformyl-2-imidazolidinone |
| 05/03/2005 | US6887877 Viricide for hepatitis virus |
| 05/03/2005 | US6887871 Use of phenylheteroakylamine derivatives |
| 05/03/2005 | US6887870 Useful as antianginal and cardioprotective agents; for therapy and prophylaxis of angina pectoris, cardiac dysfunction, myocardial necrosis, and arrhythmia |
| 05/03/2005 | US6887865 N-heterocyclic derivatives as NOS inhibitors |
| 05/03/2005 | US6887281 N-heteroarylmethyl-p-phenylenediamine derivatives as well as oxidation dyeing agents containing these compounds |
| 05/03/2005 | CA2133337C Compounds useful for treating allergic or inflammatory diseases |
| 04/28/2005 | WO2005037269A1 Novel piperidine derivative |
| 04/28/2005 | WO2005037257A2 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | WO2004083170A3 Compounds, a process for their preparation and their use as dyes and pigments |
| 04/28/2005 | WO2004014844A3 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 04/28/2005 | US20050090672 Intermediates for production of losartan; chloroformylation; hydroxylation; angiotensin II antagonists; hypertension |
| 04/28/2005 | US20050090630 Supported group 8-10 transition metal olefin polymerization catalysts |
| 04/28/2005 | US20050090504 Crohn's disease, ulcerative colitis, asthma, hypersensitivity pneumonitis, eosinophilic pneumonias, rhinitis, psoriasis, dermatitis and eczema |
| 04/28/2005 | US20050090469 Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease |
| 04/28/2005 | CA2542723A1 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/27/2005 | EP1525883A1 Ciclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 04/27/2005 | EP0906307B1 Substituted imidazoles having cytokine inhibitory activity |
| 04/27/2005 | EP0838453B1 Heterocyclic carboxylic acid derivatives and drugs containing the same |
| 04/27/2005 | CN1610660A Method for producing perfluoroalkane sulfonic acid esters and the salts thereof |
| 04/27/2005 | CN1610547A N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor |
| 04/27/2005 | CN1198817C N-(imidazolylalkyl) substituted cyclic amines as histamine-H3 agonists or antagonists |
| 04/27/2005 | CN1198805C Method for preparing optically active semi-ester |
| 04/27/2005 | CN1198803C Heterocyclic compounds having effect of activating nicoting acetylchloine alpha 4 beta 2 receptor |
| 04/26/2005 | US6884893 Selective cleavage of a cycloanhydride derivative by reacting cycloanhydride with a chiral aminoalcohol in an inert solvent to form a monoester |
| 04/26/2005 | US6884821 Alkyloxypropanoic acid derivative containing sulfonamide or amide group are useful as insulin resistance agent |
| 04/26/2005 | US6884815 An amino compound containing imidazole and aromatic, or heteroaromatic rings is useful for treating inflammatory and immune system disorders |
| 04/26/2005 | US6884808 Acids and salts such as 4-(4-(2-(2-(5,6,7,8-Tetrahydro-5,5,8, 8-tetramethylquinoxalyl))pyrrolyl))benzoic acid, used retinoic acid receptor agonists for the prophylaxis of cancer, skin disorders, asthma, alopecia or autoimmune diseases |
| 04/26/2005 | US6884801 Nitrogen compounds such as N-(4,5-dihydro-1H-imidazol-2-yl-methyl)-2-(methylsulfonyl)aniline, used for prophylaxis of incontinence |
| 04/26/2005 | US6884265 A stable direct dyes, hair dyes, like oxidation color dyes, chemical resistance, photostability, weatherproofing, wash and wear; comprising imidazolinium, triazolium and pyridinium groups |
| 04/26/2005 | CA2239053C Diphenyl pyridyl ethane derivatives as pde iv inhibitors |
| 04/21/2005 | WO2005035510A1 Derivatives of 4-phenylthiazoles and 4-phenylimidazoles and the use thereof as medicaments for treating neurodegenerative diseases, pain and epilepsy |
| 04/21/2005 | WO2005034946A1 Nonsedating α-2 agonist 1- (2, 3-dimethyl-phenyl) -ethyl-1, 3-dihydro-imizadole-2-thione |
| 04/21/2005 | WO2005034850A2 Cycloalkyl heterocycles for treating hepatitis c virus |
| 04/21/2005 | WO2004062601A3 Antibacterial agents |
| 04/21/2005 | US20050085667 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 04/21/2005 | US20050085655 Method for producing perfluoroalkane sulfonic acid esters and the salts thereof |
| 04/21/2005 | US20050085636 Reacting organoboron compound with oxypiperidine compound |
| 04/21/2005 | US20050085523 Imidazolyl and pyrazolyl ethyne compounds |
| 04/21/2005 | US20050085522 Alkylphenyliminoimidazolidine derivatives for treating urinary incontinence |
| 04/21/2005 | US20050085521 A2-phenyl-3,4-dihydroxy azole compound; drug for immunotherapy, agriculture |
| 04/21/2005 | US20050085512 Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| 04/21/2005 | US20050085507 p-phenylethenyl hydroxamates; anticarcinogenic, antitumor, antiproliferative agents; regulating p21 promoter; improved stability |
| 04/21/2005 | US20050085474 difluoroamine compounds |
| 04/21/2005 | US20050084763 low melting electrolyte comprising salts where the anionic charge is delocalized, mixed with metallic salts, polar polymers and/or aprotic solvents |
| 04/21/2005 | US20050081310 violet to dark-blue oxidative hari dyes with high intensity, stability, and water stability; color, light, wash, and rubbing fastness, storage stability |
| 04/21/2005 | DE10332684B3 Preparation of bifonazole, useful as antimycotic agent, comprises reacting biphenyl-4-yl(phenyl) methanol with chlorinating agent in cyclohexane and then with imidazole |
| 04/20/2005 | EP1524267A1 Substituted benzylaminoalkylene heterocycles |
| 04/20/2005 | EP1373249B1 Imidazolidine derivatives, their preparation, and their use as antiinflamatory agent |
| 04/20/2005 | EP1365737B1 Stable salts of o-acetylsalicyclic with basic amino acids |
| 04/20/2005 | EP1349843B1 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors |
| 04/20/2005 | EP1320534B1 Combretastatin a-4 phosphate prodrug salts with nitrogen-containing compounds |
| 04/20/2005 | EP1218351B1 Nitroimidazole derivative and diagnostic imaging agent containing the same |
| 04/20/2005 | EP1076651B1 Substituted sulphonyl cyanamides, method for producing same and their use as medicament |
| 04/20/2005 | EP1029851B1 Piperazine compounds and medicinal use thereof |
| 04/20/2005 | CN1608050A Piperazine derivative |
| 04/20/2005 | CN1607935A Primary intermediates for oxidative coloration of hair |
| 04/20/2005 | CN1197572C Hypoalbuminemia improvement agent |
| 04/19/2005 | US6881847 Process for the synthesis and recovery of nitramines |
| 04/19/2005 | US6881754 Adamantane derivatives |
| 04/19/2005 | US6881747 Small molecules for inhibition of function and drug delivery to leukocytes |
| 04/19/2005 | US6881735 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/19/2005 | US6881726 Aqueous compositions containing metronidazole |
| 04/19/2005 | US6881698 Ion liquids derived from Lewis acid based on titanium, niobium, tantalum, tin or antimony, and uses thereof |
| 04/19/2005 | US6881230 Dyeing composition for dyeing keratinous fibers comprising a cationic azo-dye |
| 04/14/2005 | WO2005033119A1 Supramolecular compounds and their use as antitumour and antiviral agents |
| 04/14/2005 | WO2005033077A1 Sequence selective pyrrole and imidazole polyamide metallocomplexes |
| 04/14/2005 | WO2004113391A3 Improved pharmaceutical drug candidates and methods for preparation thereof |
| 04/14/2005 | US20050080259 Catalyst and a method for the trimerization of isocyanates |
| 04/14/2005 | US20050080141 Amino diols useful in the treatment of alzheimer's disease |
| 04/14/2005 | US20050080123 trifluorobutenyl derivatives |
| 04/14/2005 | US20050080106 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes |
| 04/14/2005 | US20050080078 Such as [1-(4-chloro-phenyl)-cyclobutyl]-(3-hydroxymethyl piperidin-1-yl)-methadone for treating cocaine and/or methamphetamine addiction |
| 04/14/2005 | US20050080067 Omega aminoalkylamides of R-2 aryl propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 04/14/2005 | US20050080058 New vitamin D derivatives with carbo-or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments |
| 04/14/2005 | US20050080057 reducing weight in mammals; Substituted with a thio, sulfoxy or sulfonyl group eg 5-Chloro-2-methylsulfonylindan-1-ol, 5-Chloro-2-(propane-2-sulfonyl)indan-1-ol, 5-Chloro-2-ethanesulfonylindan-1-ol |
| 04/14/2005 | US20050079979 Substituted benzoylisoxazoles and the use thereof as herbicides |
| 04/13/2005 | EP1522313A1 Combination therapy of radiation and valdecoxib for the treatment of neoplasia |
| 04/13/2005 | EP1521745A1 Method for producing imidazolium salts |